XNCR Q1 2019 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$112M

Gross Profit

$84M74.8% margin

Operating Income

$78M69.9% margin

Net Income

$80M71.5% margin

EPS (Diluted)

$1.38

QoQ Revenue Growth

+868.0%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$20M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$697M

Total Liabilities

$87M

Stockholders' Equity

$610M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$112M	$0	—
Gross Profit	$84M	-$26M	+421.1%
Operating Income	$78M	-$31M	+355.3%
Net Income	$80M	-$29M	+371.4%

Revenue Segments

License

$112M100%

Research Activity

$300,0000%